PortfoliosLab logoPortfoliosLab logo
BRC vs. BSX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BRC vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Brady Corporation (BRC) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BRC achieves a 9.25% return, which is significantly higher than BSX's -53.51% return. Over the past 10 years, BRC has outperformed BSX with an annualized return of 13.17%, while BSX has yielded a comparatively lower 7.08% annualized return.


BRC

1D
-0.23%
1M
-2.75%
YTD
9.25%
6M
5.33%
1Y
29.28%
3Y*
22.72%
5Y*
10.37%
10Y*
13.17%

BSX

1D
-2.12%
1M
-23.28%
YTD
-53.51%
6M
-54.03%
1Y
-56.24%
3Y*
-6.35%
5Y*
0.25%
10Y*
7.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BRC vs. BSX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BRC
Brady Corporation
9.25%7.60%27.69%26.91%-10.91%3.75%-6.00%34.10%17.14%3.23%
BSX
Boston Scientific Corporation
-53.51%6.75%54.51%24.94%8.92%18.16%-20.50%27.96%42.56%14.61%

Correlation

The correlation between BRC and BSX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.32

Correlation (All Time)
Calculated using the full available price history since May 19, 1992

0.23

The correlation between BRC and BSX shifts across timeframes, from 0.07 (1 year) to 0.32 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

BRC:

$4.07B

BSX:

$66.27B

EPS

BRC:

$4.39

BSX:

$2.38

PE Ratio

BRC:

19.39

BSX:

18.65

PEG Ratio

BRC:

1.53

BSX:

0.42

PS Ratio

BRC:

2.51

BSX:

3.21

PB Ratio

BRC:

3.03

BSX:

2.56

Total Revenue (TTM)

BRC:

$1.62B

BSX:

$20.62B

Gross Profit (TTM)

BRC:

$828.93M

BSX:

$14.52B

EBITDA (TTM)

BRC:

$300.10M

BSX:

$4.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BRC vs. BSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BRC
BRC Risk / Return Rank: 6868
Overall Rank
BRC Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
BRC Sortino Ratio Rank: 6666
Sortino Ratio Rank
BRC Omega Ratio Rank: 7070
Omega Ratio Rank
BRC Calmar Ratio Rank: 6565
Calmar Ratio Rank
BRC Martin Ratio Rank: 7070
Martin Ratio Rank

BSX
BSX Risk / Return Rank: 11
Overall Rank
BSX Sharpe Ratio Rank: 00
Sharpe Ratio Rank
BSX Sortino Ratio Rank: 11
Sortino Ratio Rank
BSX Omega Ratio Rank: 11
Omega Ratio Rank
BSX Calmar Ratio Rank: 44
Calmar Ratio Rank
BSX Martin Ratio Rank: 11
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BRC vs. BSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Brady Corporation (BRC) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BRCBSXDifference
Sharpe ratioReturn per unit of total volatility

+2.49

Sortino ratioReturn per unit of downside risk

+3.99

Omega ratioGain probability vs. loss probability

1.22

0.64

+0.58

Calmar ratioReturn relative to maximum drawdown

1.13

-0.96

+2.08

Martin ratioReturn relative to average drawdown

3.38

-2.05

+5.43

BRC vs. BSX - Sharpe Ratio Comparison

The current BRC Sharpe Ratio is 0.88, which is higher than the BSX Sharpe Ratio of -1.61. The chart below compares the historical Sharpe Ratios of BRC and BSX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BRC vs. BSX - Drawdown Comparison

The maximum BRC drawdown since its inception was -65.62%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for BRC and BSX.


Loading charts...

Drawdown Indicators


BRCBSXDifference

Max Drawdown

Largest peak-to-trough decline

-65.62%

-89.15%

+23.53%

Max Drawdown (1Y)

Largest decline over 1 year

-26.12%

-59.01%

+32.89%

Max Drawdown (3Y)

Largest decline over 3 years

-26.12%

-59.01%

+32.89%

Max Drawdown (5Y)

Largest decline over 5 years

-26.91%

-59.01%

+32.10%

Max Drawdown (10Y)

Largest decline over 10 years

-36.21%

-59.01%

+22.80%

Current Drawdown

Current decline from peak

-11.39%

-59.01%

+47.62%

Average Drawdown

Average peak-to-trough decline

-14.41%

-38.77%

+24.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.68%

27.47%

-18.79%

Volatility

BRC vs. BSX - Volatility Comparison

Brady Corporation (BRC) has a higher volatility of 18.46% compared to Boston Scientific Corporation (BSX) at 14.47%. This indicates that BRC's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BRCBSXDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.46%

14.47%

+3.99%

Volatility (6M)

Calculated over the trailing 6-month period

29.50%

32.98%

-3.48%

Volatility (1Y)

Calculated over the trailing 1-year period

33.54%

35.03%

-1.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.24%

25.78%

+0.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.10%

27.34%

+0.76%

Dividends

BRC vs. BSX - Dividend Comparison

BRC's dividend yield for the trailing twelve months is around 1.15%, while BSX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BRC
Brady Corporation
1.15%1.23%1.28%1.58%1.92%1.64%1.65%1.49%1.92%2.17%2.16%3.49%
BSX
Boston Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

BRC vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between Brady Corporation and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
435.24M
5.20B
(BRC) Total Revenue
(BSX) Total Revenue
Values in USD except per share items

BRC vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between Brady Corporation and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%20222023202420252026
51.8%
69.4%
Portfolio components
BRC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Brady Corporation reported a gross profit of 225.47M and revenue of 435.24M. Therefore, the gross margin over that period was 51.8%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.

BRC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Brady Corporation reported an operating income of 73.21M and revenue of 435.24M, resulting in an operating margin of 16.8%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.

BRC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Brady Corporation reported a net income of 57.80M and revenue of 435.24M, resulting in a net margin of 13.3%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.


Frequently Asked Questions


BRC and BSX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BRC has higher volatility (18.46%) compared to BSX (14.47%). In terms of maximum drawdown, BRC dropped -65.62% vs BSX's -89.15%.

BRC currently has the higher Sharpe Ratio (0.88 vs -1.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BRC and BSX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer